Servitja, Sonia; Castro-Henriques, María; Álvarez-Busto, Inaki; Diez-Franco, Carlota; Medina-Castillo, Alba; Algarra-García, María-Asunción; López-Miranda, Elena; Lario-Martínez, Margaret; Luengo-Alcázar, María-Isabel; Borregón-Rivilla, Miguel; Davo, Ana; Gasull-Delgado, Anna; Roque-García, Sara; Gonzaga-López, Ana; Poveda-Ferriols, Jesús-Manuel; Pascal, Severine; Mitroi-Marinescu, Ana-María; García-Escolano, Marta; Fernández-Carvajal, Asia; Ferrandiz-Huertas, Clotilde; Ferrer-Montiel, Antonio
(SPRINGER INT PUBL AG, 2025-10-01)
BACKGROUND: Up to 80% of patients undergoing taxanes or platinum-based chemotherapy (CT) develop a peripheral polyneuropathy (CIPN), that affects treatment compliance and quality of life (QoL). CIPN is characterized by a ...